These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 24439462

  • 41. Long-term effects of therapy with ranibizumab on diabetic retinopathy severity and baseline risk factors for worsening retinopathy.
    Ip MS, Domalpally A, Sun JK, Ehrlich JS.
    Ophthalmology; 2015 Feb; 122(2):367-74. PubMed ID: 25439595
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Treatment of anti-vascular endothelial growth factor-resistant diabetic macular edema with dexamethasone intravitreal implant.
    Lazic R, Lukic M, Boras I, Draca N, Vlasic M, Gabric N, Tomic Z.
    Retina; 2014 Apr; 34(4):719-24. PubMed ID: 23975006
    [Abstract] [Full Text] [Related]

  • 47. Predictive factors for short-term visual outcome after intravitreal triamcinolone acetonide injection for diabetic macular oedema: an optical coherence tomography study.
    Brasil OF, Smith SD, Galor A, Lowder CY, Sears JE, Kaiser PK.
    Br J Ophthalmol; 2007 Jun; 91(6):761-5. PubMed ID: 17108013
    [Abstract] [Full Text] [Related]

  • 48. [Combined pharmacosurgery as treatment for diabetic macular edema: core pars plana vitrectomy and intravitreal injection of bevacizumab and triamcinolone].
    Naser H, Koss MJ, Singh P, Koch F.
    Klin Monbl Augenheilkd; 2011 Oct; 228(10):910-4. PubMed ID: 21997827
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Therapeutic interventions for macular diseases show characteristic effects on near and distance visual function.
    Munk M, Kiss C, Huf W, Sulzbacher F, Bolz M, Sayegh R, Eisenkölbl S, Simader C, Schmidt-Erfurth U.
    Retina; 2013 Oct; 33(9):1915-22. PubMed ID: 23584693
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Effects of intravitreal ranibizumab on retinal hard exudate in diabetic macular edema: findings from the RIDE and RISE phase III clinical trials.
    Domalpally A, Ip MS, Ehrlich JS.
    Ophthalmology; 2015 Apr; 122(4):779-86. PubMed ID: 25601535
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Association of retinal sensitivity and morphology during antiangiogenic treatment of retinal vein occlusion over one year.
    Kriechbaum K, Prager F, Geitzenauer W, Benesch T, Schütze C, Simader C, Schmidt-Erfurth U.
    Ophthalmology; 2009 Dec; 116(12):2415-21. PubMed ID: 19744723
    [Abstract] [Full Text] [Related]

  • 56. Diabetic Macular Edema at the time of Cataract Surgery trial: a prospective, randomized clinical trial of intravitreous bevacizumab versus triamcinolone in patients with diabetic macular oedema at the time of cataract surgery - preliminary 6 month results.
    Lim LL, Morrison JL, Constantinou M, Rogers S, Sandhu SS, Wickremasinghe SS, Kawasaki R, Al-Qureshi S.
    Clin Exp Ophthalmol; 2016 May; 44(4):233-42. PubMed ID: 26871700
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.
    Nguyen QD, Brown DM, Marcus DM, Boyer DS, Patel S, Feiner L, Gibson A, Sy J, Rundle AC, Hopkins JJ, Rubio RG, Ehrlich JS, RISE and RIDE Research Group.
    Ophthalmology; 2012 Apr; 119(4):789-801. PubMed ID: 22330964
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Intravitreal bevacizumab vs intravitreal triamcinolone combined with macular laser grid for diffuse diabetic macular oedema.
    Forte R, Cennamo GL, Finelli M, Farese E, D'Amico G, Nicoletti G, de Crecchio G, Cennamo G.
    Eye (Lond); 2010 Aug; 24(8):1325-30. PubMed ID: 20300127
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.